Cargando…

Muscular dystrophy with arrhythmia caused by loss-of-function mutations in BVES

OBJECTIVE: To study the genetic and phenotypic spectrum of patients harboring recessive mutations in BVES. METHODS: We performed whole-exome sequencing in a multicenter cohort of 1929 patients with a suspected hereditary myopathy, showing unexplained limb-girdle muscular weakness and/or elevated cre...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Ridder, Willem, Nelson, Isabelle, Asselbergh, Bob, De Paepe, Boel, Beuvin, Maud, Ben Yaou, Rabah, Masson, Cécile, Boland, Anne, Deleuze, Jean-François, Maisonobe, Thierry, Eymard, Bruno, Symoens, Sofie, Schindler, Roland, Brand, Thomas, Johnson, Katherine, Töpf, Ana, Straub, Volker, De Jonghe, Peter, De Bleecker, Jan L., Bonne, Gisèle, Baets, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501641/ https://www.ncbi.nlm.nih.gov/pubmed/31119192 http://dx.doi.org/10.1212/NXG.0000000000000321

Ejemplares similares

A common French-Italian laminopathy registry – update & future prospects
por: Bonne, Gisèle, et al.
Publicado: (2015)

Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy
por: De Paepe, Boel, et al.
Publicado: (2013)

Bves Modulates Tight Junction Associated Signaling
por: Russ, Patricia K., et al.
Publicado: (2011)

Abnormal NFAT5 Physiology in Duchenne Muscular Dystrophy Fibroblasts as a Putative Explanation for the Permanent Fibrosis Formation in Duchenne Muscular Dystrophy
por: Herbelet, Sandrine, et al.
Publicado: (2020)

Description of a Novel Mechanism Possibly Explaining the Antiproliferative Properties of Glucocorticoids in Duchenne Muscular Dystrophy Fibroblasts Based on Glucocorticoid Receptor GR and NFAT5
por: Herbelet, Sandrine, et al.
Publicado: (2020)

The Tumor Necrosis Factor Superfamily of Cytokines in the Inflammatory Myopathies: Potential Targets for Therapy
por: De Paepe, Boel, et al.
Publicado: (2012)

An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis
por: De Paepe, Boel, et al.
Publicado: (2022)

Retrospective Study Shows That Serum Levels of Chemokine CXCL10 and Cytokine GDF15 Support a Diagnosis of Sporadic Inclusion Body Myositis and Immune-Mediated Necrotizing Myopathy
por: De Paepe, Boel, et al.
Publicado: (2023)

An overview of new translational, clinical and therapeutic perspectives in laminopathies and other nuclear envelope-related diseases.
por: De Sandre-Giovannoli, Annachiara, et al.
Publicado: (2015)

Laminopathies’ Treatments Systematic Review: A Contribution Towards a ‘Treatabolome’
por: Atalaia, Antonio, et al.
Publicado: (2021)

Anti-Inflammatory and General Glucocorticoid Physiology in Skeletal Muscles Affected by Duchenne Muscular Dystrophy: Exploration of Steroid-Sparing Agents
por: Herbelet, Sandrine, et al.
Publicado: (2020)

Identification of a Novel Intracellular Interaction Domain Essential for Bves Function
por: Kawaguchi, Michiya, et al.
Publicado: (2008)

BVES is a novel interactor of ANO5 and regulates myoblast differentiation
por: Li, Haiwen, et al.
Publicado: (2021)

Defective BVES-mediated feedback control of cAMP in muscular dystrophy
por: Li, Haiwen, et al.
Publicado: (2023)

Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis
por: De Paepe, Boel, et al.
Publicado: (2020)

Preclinical Advances of Therapies for Laminopathies
por: Benarroch, Louise, et al.
Publicado: (2021)

A Muscle Hybrid Promoter as a Novel Tool for Gene Therapy
por: Piekarowicz, Katarzyna, et al.
Publicado: (2019)

Popeye Domain Containing 1 (Popdc1/Bves) Is a Caveolae-Associated Protein Involved in Ischemia Tolerance
por: Alcalay, Yifat, et al.
Publicado: (2013)

Induction of Osmolyte Pathways in Skeletal Muscle Inflammation: Novel Biomarkers for Myositis
por: De Paepe, Boel, et al.
Publicado: (2018)

Clinical heterogeneity and phenotype/genotype findings in 5 families with GYG1 deficiency
por: Ben Yaou, Rabah, et al.
Publicado: (2017)

BVES Is Required for Maintenance of Colonic Epithelial Integrity in Experimental Colitis by Modifying Intestinal Permeability
por: Choksi, Yash A., et al.
Publicado: (2018)

Ten years of research on the role of BVES/ POPDC1 in human disease: a review
por: Han, Ping, et al.
Publicado: (2019)

BVES downregulation in non-syndromic tetralogy of fallot is associated with ventricular outflow tract stenosis
por: Shi, Yan, et al.
Publicado: (2020)

Laminin α2 Deficiency-Related Muscular Dystrophy Mimicking Emery-Dreifuss and Collagen VI related Diseases
por: Nelson, Isabelle, et al.
Publicado: (2015)

Description of Osmolyte Pathways in Maturing Mdx Mice Reveals Altered Levels of Taurine and Sodium/Myo-Inositol Co-Transporters
por: Merckx, Caroline, et al.
Publicado: (2022)

Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras
por: De Paepe, Boel
Publicado: (2019)

Progressive Skeletal Muscle Atrophy in Muscular Dystrophies: A Role for Toll-Like Receptor-Signaling in Disease Pathogenesis
por: De Paepe, Boel
Publicado: (2020)

The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker
por: De Paepe, Boel
Publicado: (2022)

Incorporating circulating cytokines into the idiopathic inflammatory myopathy subclassification toolkit
por: De Paepe, Boel
Publicado: (2023)

What Nutraceuticals Can Do for Duchenne Muscular Dystrophy: Lessons Learned from Amino Acid Supplementation in Mouse Models
por: De Paepe, Boel
Publicado: (2023)

Expanding the TDP-43 Proteinopathy Pathway From Neurons to Muscle: Physiological and Pathophysiological Functions
por: Versluys, Lauren, et al.
Publicado: (2022)

Bves and NDRG4 regulate directional epicardial cell migration through autocrine extracellular matrix deposition
por: Benesh, Emily C., et al.
Publicado: (2013)

Cell adhesion molecule BVES functions as a suppressor of tumor cells extrusion in hepatocellular carcinoma metastasis
por: Han, Ping, et al.
Publicado: (2022)

Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse
por: Merckx, Caroline, et al.
Publicado: (2022)

C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD
por: Ervilha Pereira, Pedro, et al.
Publicado: (2023)

Lamin A/C Assembly Defects in LMNA-Congenital Muscular Dystrophy Is Responsible for the Increased Severity of the Disease Compared with Emery–Dreifuss Muscular Dystrophy
por: Bertrand, Anne T., et al.
Publicado: (2020)

Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies
por: De Paepe, Boel, et al.
Publicado: (2015)

The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy
por: Merckx, Caroline, et al.
Publicado: (2022)

A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders
por: De Paepe, Boel, et al.
Publicado: (2017)

The PKA-p38MAPK-NFAT5-Organic Osmolytes Pathway in Duchenne Muscular Dystrophy: From Essential Player in Osmotic Homeostasis, Inflammation and Skeletal Muscle Regeneration to Therapeutic Target
por: Herbelet, Sandrine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8dit7bqsktcihtn1hmeku0v192